Disclosed are substituted imidazo[1,2-a]pyridines, imidazo[1,2-a]pyrazines, imidazo[1,2-c]pyrimidines and imidazo[1,2-d]triazines compounds of the formula: (1.0) Also disclosed are methods for treating JNK1 and ERK mediated diseases using the compounds of formula 1.0.
本发明涉及代替的
咪唑[1,2-a]
吡啶,
咪唑[1,2-a]
吡嗪,
咪唑[1,2-c]
嘧啶和
咪唑[1,2-d]三嗪化合物,其
化学式为:(1.0)。本发明还涉及使用化合物1.0治疗JNK1和ERK介导的疾病的方法。